This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200707-1096OCv1 177/9/959    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pantano, C. Articles by Janssen-Heininger, Y. M. W. Search for Related Content PubMed PubMed Citation Articles by Pantano, C. Articles by Janssen-Heininger, Y. M. W.

Nuclear Factor-B Activation in Airway Epithelium Induces Inflammation and Hyperresponsiveness

¹ Department of Pathology and ² Department of Medicine, University of Vermont, Burlington, Vermont

Correspondence and requests for reprints should be addressed to Yvonne M.W. Janssen-Heininger, Ph.D., Department of Pathology, University of Vermont, Burlington, Vermont 05405. E-mail: yvonne.janssen{at}uvm.edu

Rationale: Nuclear factor (NF)-B is a prominent proinflammatory transcription factor that plays a critical role in allergic airway disease. Previous studies demonstrated that inhibition of NF-B in airway epithelium causes attenuation of allergic inflammation.

Objectives: We sought to determine if selective activation of NF-B within the airway epithelium in the absence of other agonists is sufficient to cause allergic airway disease.

Methods: A transgenic mouse expressing a doxycycline (Dox)-inducible, constitutively active (CA) version of inhibitor of B (IB) kinase-β (IKKβ) under transcriptional control of the rat CC10 promoter, was generated.

Measurements and Main Results: After administration of Dox, expression of the CA-IKKβ transgene induced the nuclear translocation of RelA in airway epithelium. IKKβ-triggered activation of NF-B led to an increased content of neutrophils and lymphocytes, and concomitant production of proinflammatory mediators, responses that were not observed in transgenic mice not receiving Dox, or in transgene-negative littermate control animals fed Dox. Unexpectedly, expression of the IKKβ transgene in airway epithelium was sufficient to cause airway hyperresponsiveness and smooth muscle thickening in absence of an antigen sensitization and challenge regimen, the presence of eosinophils, or the induction of mucus metaplasia.

Conclusions: These findings demonstrate that selective activation NF-B in airway epithelium is sufficient to induce airway hyperresponsiveness and smooth muscle thickening, which are both critical features of allergic airway disease.

Key Words: airway epithelium • nuclear factor-B • inhibitory B kinase-β • airway hyperresponsiveness • smooth muscle cell

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Nuclear factor (NF)-B activation contributes to allergic airway disease, but it is not known whether activation of NF-B in absence of other stimuli is sufficient to cause allergic airway disease. What This Study Adds to the Field This study shows that NF-B activation in airways is sufficient to trigger certain parameters of allergic disease and highlights the potential clinical benefit on focused targeting of the NF-B pathway within the airways.

 

This article has been cited by other articles:

				J. H. T. Bates, M. Rincon, and C. G. Irvin Animal models of asthma Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L401 - L410. [Abstract] [Full Text] [PDF]

				K. Page, J. R. Ledford, P. Zhou, and M. Wills-Karp A TLR2 Agonist in German Cockroach Frass Activates MMP-9 Release and Is Protective against Allergic Inflammation in Mice J. Immunol., September 1, 2009; 183(5): 3400 - 3408. [Abstract] [Full Text] [PDF]

				C. Wagner, K. Isermann, and T. Roeder Infection induces a survival program and local remodeling in the airway epithelium of the fly FASEB J, July 1, 2009; 23(7): 2045 - 2054. [Abstract] [Full Text] [PDF]

				T. Roeder, K. Isermann, and M. Kabesch Drosophila in Asthma Research Am. J. Respir. Crit. Care Med., June 1, 2009; 179(11): 979 - 983. [Abstract] [Full Text] [PDF]

				W. C. Moore Update in Asthma 2008 Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 869 - 874. [Full Text] [PDF]

				L. T. Krug, C. M. Collins, L. M. Gargano, and S. H. Speck NF-{kappa}B p50 Plays Distinct Roles in the Establishment and Control of Murine Gammaherpesvirus 68 Latency J. Virol., May 15, 2009; 83(10): 4732 - 4748. [Abstract] [Full Text] [PDF]

				Y. M. W. Janssen-Heininger, M. E. Poynter, S. W. Aesif, C. Pantano, J. L. Ather, N. L. Reynaert, K. Ckless, V. Anathy, J. van der Velden, C. G. Irvin, et al. Nuclear Factor {kappa}B, Airway Epithelium, and Asthma: Avenues for Redox Control Proceedings of the ATS, May 1, 2009; 6(3): 249 - 255. [Abstract] [Full Text] [PDF]

				H. A. Boushey Thomas L. Petty Aspen Lung Conference: Asthma: Insights and Expectations. Conference summary. Proceedings of the ATS, May 1, 2009; 6(3): 316 - 320. [Full Text] [PDF]

				Z. Bao, S. Guan, C. Cheng, S. Wu, S. H. Wong, D. M. Kemeny, B. P. Leung, and W. S. F. Wong A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-{kappa}B Pathway Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 657 - 665. [Abstract] [Full Text] [PDF]